IE830285L - Use of cholecalciferol derivatives - Google Patents

Use of cholecalciferol derivatives

Info

Publication number
IE830285L
IE830285L IE830285A IE28583A IE830285L IE 830285 L IE830285 L IE 830285L IE 830285 A IE830285 A IE 830285A IE 28583 A IE28583 A IE 28583A IE 830285 L IE830285 L IE 830285L
Authority
IE
Ireland
Prior art keywords
alpha
dihydroxycholecalciferol
cholecalciferol derivatives
cholecalciferol
derivatives
Prior art date
Application number
IE830285A
Other versions
IE54722B1 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IE830285L publication Critical patent/IE830285L/en
Publication of IE54722B1 publication Critical patent/IE54722B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. The C-25 R- or S-epimer of 1 alpha,25,26-trihydroxycholecalciferol as an active substance for the treatment of disease states, which are characterized by a level of endogenously-produced 1 alpha,25-dihydroxycholecalciferol in the serum which lies above the normal value or by an increased sensitivity to 1 alpha,25-dihydroxycholecalciferol. [EP0086476A2]
IE285/83A 1982-02-12 1983-02-11 Use of cholecalciferol derivatives IE54722B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34838982A 1982-02-12 1982-02-12

Publications (2)

Publication Number Publication Date
IE830285L true IE830285L (en) 1983-08-12
IE54722B1 IE54722B1 (en) 1990-01-17

Family

ID=23367827

Family Applications (1)

Application Number Title Priority Date Filing Date
IE285/83A IE54722B1 (en) 1982-02-12 1983-02-11 Use of cholecalciferol derivatives

Country Status (12)

Country Link
EP (1) EP0086476B1 (en)
JP (1) JPS58148822A (en)
AU (1) AU560066B2 (en)
BE (1) BE895884A (en)
CA (1) CA1206882A (en)
DE (2) DE3304819A1 (en)
IE (1) IE54722B1 (en)
IL (1) IL67881A0 (en)
IT (1) IT1173654B (en)
NZ (1) NZ203251A (en)
PH (1) PH17993A (en)
ZA (1) ZA83923B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59155309A (en) * 1983-02-22 1984-09-04 Teijin Ltd Active type vitamin d3 composition and its preparation
AU575373B2 (en) * 1984-02-08 1988-07-28 F. Hoffmann-La Roche Ag Calciferol derivatives
JPS6391323A (en) * 1986-10-03 1988-04-22 Kureha Chem Ind Co Ltd Antiurinary calculosis agent
EP0313703B1 (en) * 1987-10-30 1990-09-26 Kureha Kagaku Kogyo Kabushiki Kaisha Use of 24,25-dihydroxycholecalciferole in the treatment of urinary calculus
JP2856444B2 (en) * 1989-07-28 1999-02-10 呉羽化学工業株式会社 Vitamin D lower 3 metabolite preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH644100A5 (en) * 1979-09-14 1984-07-13 Hoffmann La Roche CHOLECALCIFEROL DERIVATIVES.

Also Published As

Publication number Publication date
JPH0474332B2 (en) 1992-11-26
AU1134083A (en) 1983-08-18
PH17993A (en) 1985-02-28
DE3304819A1 (en) 1983-08-25
AU560066B2 (en) 1987-03-26
IT1173654B (en) 1987-06-24
EP0086476B1 (en) 1986-05-07
JPS58148822A (en) 1983-09-05
IE54722B1 (en) 1990-01-17
EP0086476A2 (en) 1983-08-24
IL67881A0 (en) 1983-06-15
ZA83923B (en) 1983-11-30
CA1206882A (en) 1986-07-02
EP0086476A3 (en) 1983-11-09
DE3363334D1 (en) 1986-06-12
IT8319545A0 (en) 1983-02-11
BE895884A (en) 1983-08-11
NZ203251A (en) 1986-04-11

Similar Documents

Publication Publication Date Title
AU534412B2 (en) Running shoe with wedged sole
AU2185388A (en) Sport sandal for active wear
AU523539B2 (en) Running shoe
IE812367L (en) Anti-acne compositions
EP0343444A3 (en) Cosmetic composition containing retinyl palmitate
IE830285L (en) Use of cholecalciferol derivatives
IL72188A0 (en) Imidazoquinazoline derivative and salts thereof,their preparation and pharmaceutical compositions containing them
AU542529B2 (en) 3,4-bis-substituted 1,2,5-oxadiazole 2-oxides
AU578664B2 (en) Liquid,cinnamal dialkyl malonates as sole organic sunscreens
IE790833L (en) Preparation of trifluoromethylphenols
AU550096B2 (en) Dibenzo-1,4-dioxepins and their thia analogues
AU533517B2 (en) 4,1-benzoxazepines and thia analogues
AU7317287A (en) 5,6,8-triflouro-quinol-4-one-3-carboxylic acid derivatives
EP0286601A3 (en) Powdered deodorant composition for shoes, in particular for sporting shoes
IE850213L (en) Dihydroxy dehydrovitamin d compound
AU1543283A (en) Biostimulating agent containing creatine
AU4572279A (en) Low calcium xanthan gum
EP0112299A3 (en) Method for superoxidic-dismutasis purification via chromatography by affinity
IE831131L (en) Use of a cholecalciferol derivative
JPS5436255A (en) Novel sesquiterpene analogue, its preparation, and pharmatheutical containing the same
AU8974282A (en) Shoe stiffener
IL68195A (en) Dermatological preparations containing as active ingredients 1alpha-hydroxycholecalciferol or 1alpha,25-dihydroxy-cholecalciferol
AU1242983A (en) Physiologically active pterocarpan compounds
EP0103955A3 (en) Treatment of athlete's foot
AU557949B2 (en) 5-phenyl substituted cyclohexane 1,3 dione derivatives